To Joins Wells Fargo’s Corporate & Investment Banking Healthcare Group



Lucy To joined Wells Fargo Corporate & Investment Banking’s healthcare coverage group as a managing director focused on the biotech investment banking sector. Based in New York, To will report to John Fowler, head of healthcare within the CIB Coverage group.

“To’s appointment further demonstrates Wells Fargo’s commitment to the healthcare/biotechnology sector,” David Gillespie, head of CIB Coverage at Wells Fargo, said. “With close to 15 years [of] biotechnology experience, including cross-border expertise in capital raising, mergers and acquisitions and IPOs, she brings deep industry knowledge and we look forward to her contributions within our healthcare group.”

To joined Wells Fargo from Deutsche Bank, where she focused on healthcare investment banking coverage of biopharma companies. Prior to that she worked in business development at Intercept Pharmaceuticals and in healthcare investment banking at Citigroup and Cowen.


Like this story? Begin each business day with news you need to know! Register now for FREE Daily E-News Broadcast and start YOUR day informed!

Leave a comment

View Latest Digital Edition

Terry Mulreany
Subscriptions: 800 708 9373 x130
terry.mulreany@monitordaily.com
Susie Angelucci
Advertising: 484.459.3016
susie.angelucci@monitordaily.com

View Latest Digital Edition

Visit our sister website for news, information, exclusive articles,
deal tables and more on the asset-based lending, factoring,
and restructuring industries.
www.abfjournal.com